Genomcore receives almost one million Euros from Next Generation EU in the largest funded Artificial Intelligence project - #BHHMembersInitiatives
Home News Genomcore receives almost one million Euros from Next Generation EU in the largest funded Artificial Intelligence project - #BHHMembersInitiatives

Genomcore receives almost one million Euros from Next Generation EU in the largest funded Artificial Intelligence project - #BHHMembersInitiatives

MARCH 7, 2022 BHH News
BHH member Genomcore S.L., also known for its line of personalized health services under the brand Made of Genes, announces from its business line of consulting and digital solutions environment biomedical data governance its participation in the Big Data and Artificial Intelligence project DIPCAN (Digitization and integrated management of personalized medicine). This project granted from the Secretary of State for Digitalization and Artificial Intelligence (SEDIA), the highest body of the Ministry of Economic Affairs and Digital Transformation, is provided with funding from the European Union, within the Next Generation EU program, which will cover approximately 7.5 million euros of the consortium's overall budget (10,692,931 euros) and where Genomcore will receive 919,610.22 euros of these European funds out of a total budgeted amount of 1,149,512.77 euros (80%). DIPCAN, aims to change clinical practice in the area of oncology, betting on personalized medicine, where from a better knowledge of the oncological disease of each patient, personalized treatment therapies directed to the molecular alterations found will be possible. To this end, an Artificial Intelligence system will be developed based on the integration of different sources of clinical, radiomic, histopathological and genetic data from a total of 2000 patients with metastatic cancer in Spain. The integration, structuring and analysis of this data will allow the generation of a standardized clinical report, a digital histopathology report with corresponding images, a total body magnetic resonance imaging ("MRI") report, a sequencing and gene expression report, as well as the final recommendation by the oncologist that will help to better understand the disease and enable the patient's access to state-of-the-art therapies and clinical trials. The project will last two years and, apart from Genomcore, will include the participation of leading companies in the sector such as the MD Anderson Foundation Spain, Eurofins Megalab, Artelnics, Pangaea Oncology, Quibim and Atrys Health. Within the development of the project, Genomcore will lead and coordinate the integration, structuring and governance of data following the strategic line of the company in offering digital solutions that allow the effective implementation of personalized medicine in clinical environments where the management of personal data is critical to comply with current regulations in terms of security and privacy, while its standardization for a multidisciplinary treatment. In the words of Dr. Oscar Flores, Genomcore's CEO: "We are living the digital transformation of the healthcare sector towards a data-driven medicine of a complexity that has never been seen before. To the volume of biomedical data derived from -omics techniques is added its highly sensitive personal and clinical data nature, which requires not only an extensive mastery of technology but also new protocols and implementations aware of the regulatory environment and patients' rights." He also adds: "From Genomcore, we are proud to have positioned ourselves as the reference partner in the management of personal bio-health data for the implementation of personalized medicine by both hospitals, research centers or the biopharmaceutical industry with disruptive projects such as DIPCAN."
February 16, 2024 4YFN BHH News
BHH ON AIR with 4YFN at Revolució 4.0 at Catalunya Ràdio
If you’re looking for a quick catch-up about all things related to digital health, don’t miss BHH this weekend at Catalunya Ràdio!
Read more
February 01, 2024 BHH News
BHH ON AIR with Astrazeneca at Revolució 4.0 at Catalunya Ràdio
If you’re looking for a quick catch-up about all things related to digital health, don’t miss BHH this weekend at Catalunya Ràdio!
Read more
January 24, 2024 BHH News
Sanofi reinforces its commitment to digital innovation by joining Barcelona Health Hub
The company consolidates its position in the city's digital health ecosystem, where its Global Innovation Center is located.
Read more
January 18, 2024 BHH News
Novo Nordisk joins Barcelona Health Hub to drive digital solutions applied to healthcare
Novo Nordisk takes another step forward in its efforts to improve the quality of life of patients as part of its commitment to innovation.
Read more
January 11, 2024 BHH News
BHH ON AIR with Qualifyze at Revolució 4.0 at Catalunya Ràdio
If you’re looking for a quick catch-up about all things related to digital health, don’t miss BHH this weekend at Catalunya Ràdio!
Read more
January 11, 2024 BHH News
Let’s welcome the new BHH Ambassadors
Barcelona Health Hub is proud to start the new year with brand new BHH Ambassadors!
Read more
January 02, 2024 BHH News
Special discounts for BHH Residents
Check out these special discounts available for BHH Residents. 
Read more
December 28, 2023 BHH News
#BHHInterview with COCO
Barcelona Health Hub had the pleasure to meet up with Robert Parada, CEO of BHH member COCO Tecnologías a few weeks ago.
Read more
December 28, 2023 BHH News
Sign up for InnoBuyer's Open Call for Solvers
The InnoBuyer Call for Solvers aims to select 15 innovative SMEs (Solvers), to co-develop pilots with public organisations (Challengers).
Read more
December 20, 2023 BHH News
BHH opened its 4th pavilion!
The digital health ecosystem of Barcelona Health Hub is growing every day. More than 500 healthcare companies and organizations form part of the community and this number is increasing on a daily basis.
Read more